Oncoclinicas do Brasil (ONCO3) — Cash Flow Reinvestment Rate
Oncoclinicas do Brasil (ONCO3) has a Cash Flow Reinvestment Rate of 0.91x as of September 2025, reinvesting R$138.30 Million (capex R$52.99 Million plus investments R$-85.31 Million) from operating cash flow of R$151.75 Million. Check ONCO3 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncoclinicas do Brasil Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Oncoclinicas do Brasil across 6 annual periods. Explore Oncoclinicas do Brasil cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Oncoclinicas do Brasil (2013–2020)
Year-by-year capital reinvestment analysis for Oncoclinicas do Brasil. For live market cap and broader valuation context, see market value of Oncoclinicas do Brasil.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.76x | R$268.98 Million | R$97.56 Million | R$204.80 Million | ▲ +35.4% |
| 2019 | 2.04x | R$197.73 Million | R$97.08 Million | R$190.19 Million | ▼ -67.0% |
| 2018 | 6.17x | R$239.70 Million | R$38.86 Million | R$238.45 Million | ▲ +2225.0% |
| 2017 | 0.27x | R$35.89 Million | R$135.26 Million | R$34.64 Million | ▼ -83.1% |
| 2014 | 1.57x | R$14.57 Million | R$9.29 Million | R$14.57 Million | ▼ -30.5% |
| 2013 | 2.26x | R$16.58 Million | R$7.34 Million | R$16.58 Million | — |